In response to news reports of unusually high wholesale price increases in brand-name prescription drugs, Democrats in Congress asked for two separate investigations of drug industry pricing as they continue working on legislation to overhaul the nation's healthcare system. Although drug makers challenge the theory, some experts say the run-up in wholesale prices may be partly related to the industry's concerns about future cost containment under any healthcare legislation, the New York Times reports.
